Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001193125-25-288632

Chief Legal Officer sold 1,635 shares at $10.59 ($17,315)

  • Chief Legal Officer acquired 1,635 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bizily Scott Chief Legal Officer 2025-11-17 Option exercise 10b5-1 +1,635 $4.14 $6,769 5,229 D
Bizily Scott Chief Legal Officer 2025-11-17 Sale 10b5-1 −1,635 $10.59 $17,315 3,594 D
Derivatives
Bizily Scott Chief Legal Officer 2025-11-17 Option exercise · Stock Option (Right to Buy) 10b5-1 −1,635 75,230 D
Open-market sales · 1,635 sh · avg $10.59 · $17,315
Loading xslF345X05/ownership.xml…